In terms of market performance, Coherus Biosciences Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $2.43 on 12/03/24, while the lowest value was $0.66 on 11/05/24.
52-week price history of CHRS Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Coherus Biosciences Inc’s current trading price is -66.05% away from its 52-week high, while its distance from the 52-week low is 24.96%. The stock’s price range during this period has fluctuated between $0.66 and $2.43. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 4.65 million for the day, which was evidently higher than the average daily volume of 1.79 million over the last three months.
Financial Performance and Market Capitalization
Coherus Biosciences Inc (CHRS) has experienced a quarterly decline of -25.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 95.62M and boasts a workforce of 228 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1274, with a change in price of -0.8749. Similarly, Coherus Biosciences Inc recorded 1,981,221 in trading volume during the last 100 days, posting a change of -51.46%.
CHRS Stock Stochastic Average
The raw stochastic average for Coherus Biosciences Inc over the last 50 days is presently at 22.26%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 1.50%. Further, the company’s Stochastic %K and %D values for the last 20 days were 35.95% and 48.95%, respectively.
CHRS Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -40.21%.However, over the last six months, we can see a weaker performance of 0.62%. Over the last 30 days, the price of CHRS has leaped by -1.29%. And in the last five days, it has fallen by -11.27%.
